Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

Question 2

How does OMP-305B83 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the combination of OMP-305B83 and FOLFIRI or FOLFOX?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer clinical trial (NCT03035253). Contact the study team or your healthcare provider for specific answers.

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study)

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Trial snapshot

Condition

Locations shown

For caregivers